News stories about Sabra Health Care REIT (NASDAQ:SBRA) have been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sabra Health Care REIT earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned media stories about the real estate investment trust an impact score of 44.9940206849784 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
- Sabra Health Care REIT, Inc. (SBRA) – Watch List stock – Wall Street Morning (wallstreetmorning.com)
- $157.80 Million in Sales Expected for Sabra Health Care REIT Inc (SBRA) This Quarter (americanbankingnews.com)
- Don’t omit Stocks in Wall Street: Sabra Health Care REIT, Inc. (SBRA) – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Jefferies Downgrades Sabra Healthcare REIT Inc. (SBRA) to Hold, Says Execution Risk Around the Genesis Portfolio Sale Creates an Overhang (streetinsider.com)
- $0.67 EPS Expected for Sabra Health Care REIT Inc (SBRA) This Quarter (americanbankingnews.com)
A number of equities analysts recently issued reports on the stock. Mizuho upgraded shares of Sabra Health Care REIT from an “underperform” rating to a “neutral” rating and upped their price objective for the stock from $23.00 to $24.00 in a research report on Monday, September 11th. Zacks Investment Research cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Friday, September 22nd. Bank of America upped their price objective on shares of Sabra Health Care REIT from $21.00 to $22.00 and gave the stock an “underperform” rating in a research report on Friday, September 8th. Cantor Fitzgerald reissued a “buy” rating and set a $30.00 target price on shares of Sabra Health Care REIT in a report on Friday, September 8th. Finally, Jefferies Group reissued a “buy” rating and set a $24.00 target price (down from $25.00) on shares of Sabra Health Care REIT in a report on Wednesday, September 27th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. Sabra Health Care REIT currently has an average rating of “Hold” and a consensus price target of $24.40.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date was Tuesday, November 14th. Sabra Health Care REIT’s dividend payout ratio is currently 266.67%.
In related news, Director Milton J. Walters sold 4,615 shares of the business’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total transaction of $88,515.70. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 2.60% of the company’s stock.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
What are top analysts saying about Sabra Health Care REIT? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sabra Health Care REIT and related companies.